Bristol-Myers Squibb Company stock price

Today's NYSE:BMY chart, history & news

Price:
63.81 USD
Change:
+0.23 (0.36%)
Trade Buy
67% of retail CFD accounts lose money

Key stats

Price open 63.75
Previous close 63.58
Market cap 142.55B
Volume 6.47M
Day high 63.96
Day low 63.58
Year high 66.64
Year low 52.43
Year to date change 4.03%
P/E ratio -15.99
Company Profile
Fundamentals
Insider Information
News

About Bristol-Myers Squibb Company

Established in 1887 by William McLaren Bristol and John Ripley Myers, Bristol-Myers Squibb Company is a pharmaceutical company. Headquartered in New York, the company specializes in the development, manufacturing, licensing, and distribution of a wide range of pharmaceutical products.

The company’s pipeline of drugs includes novel treatments for oncology, immunoscience as well as cardiovascular and fibrotic illnesses. It’s lead products is Opdivo, a novel treatment for anti-cancer indications. It also sales Eliquis an oral inhibitor for stroke prevention as well as Orencia for patients with prostate-specific antigen.

Bristol-Myers Squibb Company has grown to become a juggernaut in the pharmaceutical space through acquisitions. Its biggest acquisition to date is that of Celgene in a deal valued at $74 billion. The acquisition should strengthen the company’s pipeline for cancer drugs and shrug of the effects of declining sales for lead product Opdivo.

Bristol-Myers Squibb Company has its stock listed on the New York Stock Exchange and is a component of the S&P 500 and S&P 100.

Company information

Company name
Bristol-Myers Squibb Company
Exchange
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Employees
30,000
CEO
Giovanni Caforio
Address
430 E 29th St Fl 14, New York, New York, 10016-8367
Country
United States
Contact information
12125464000
Website
https://www.bms.com/